Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 2/2010

01-02-2010 | Letter

The economic costs of diabetes in developing countries: some concerns and recommendations

Authors: A. K. Khuwaja, L. A. Khowaja, P. Cosgrove

Published in: Diabetologia | Issue 2/2010

Login to get access

Excerpt

To the Editor: We read with great interest the recently published article by Esteghamati and colleagues [1] entitled ‘The economic costs of diabetes: a population-based study in Tehran, Iran’. The authors are to be congratulated for their admirable work in measuring the economic burden of diabetes, a disease for which the number of people affected is growing rapidly in developing countries [2]. With reference to the article, we wish to comment on the growing burden of diabetes—especially in the context of developing countries—and then go on to make some recommendations. …
Literature
1.
Esteghamati A, Khalilzadeh O, Anvari M et al (2009) The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia 52:1520–1527CrossRefPubMed
2.
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
3.
International Diabetes Association (2003) Diabetes atlas, 2nd edn. International Diabetes Association, Brussels
4.
5.
Khowaja LA, Khuwaja AK, Cosgrove P (2007) Cost of diabetes care in out-patient clinics of Karachi, Pakistan. BMC Health Serv Res 21:189CrossRef
6.
Ramachandran A, Ramachandran S, Snehalatha C et al (2007) Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India. Diabetes Care 30:252–256CrossRefPubMed
7.
8.
Elliot R, Payne K (2005) Essentials of economic evaluation in healthcare. Pharmaceutical Press, London
9.
Kermani MS, Ghaderi H, Yousefi A (2008) Demand for medical care in the urban areas of Iran: an empirical investigation. Health Econ 17:849–862CrossRefPubMed
Metadata
Title
The economic costs of diabetes in developing countries: some concerns and recommendations
Authors
A. K. Khuwaja
L. A. Khowaja
P. Cosgrove
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1581-7

Other articles of this Issue 2/2010

Diabetologia 2/2010 Go to the issue

Article

Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

Article

Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice

Article

Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study

Erratum

Erratum to: Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity

Article

Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice

Article

Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits